rfhg_177066.1

Basic information about the TSS

---

TSS ID: rfhg_177066.1 TSS ID(Version3): hg_226097.1 hg_147946.1 hg_147948.1 hg_147947.1 Species: human Chr: chr15		Start: 79311085 End: 79311276 Strand: +
Source datasets	FANTOM5|PRJNA4843412|PRJNA548673|PRJNA401781|DRA013844 |PRJNA615891|PRJDB5282
Protocol	CAGE|NETCAGE|ReCappable-seq|oligo_capping|SLIC_CAGE |TIF-seq2|C1CAGE
TSS cluster detected*	10

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2814661,EH38E1781110)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000299705.10:0 ENST00000424155.6:0 ENST00000536821.5:0 ENST00000543455.1:0 BC111547:0 BC010853:0 AK222516:0 BC022232:0 AK289434:0 AK297710:0 HM005671:0 BC017495:0 AL109672:0 AY358974:0 BC000027:0 AK304148:0 AK075529:0 AJ132270:0 CR457384:0 GeneID: 23423 HGNC/MGI_ID: HGNC:28889 UniProt_ID: A0A140VKD1 B4E277 F5H4M7 G3V1J9 Q53HR4 Q8N2D9 Q9Y3Q3 Nearer transcript ids and distances:

Gene_name: transmembrane p24 trafficking protein 3 Gene_symbol: TMED3 Gene_synonyms: p24B p24g4 p24gamma4 Gene_source: HGNC:28889

TATA-Box annotation

---

Distance to TSS:	68
Nearest PromoterID:	NM_007364
Entrez ID:	23423
Nearest Unigene:	Hs.71608
Nearest Refseq:	NM_007364
Nearest Ensembl:	ENSG00000166557
Gene Name:	transmembrane p24 trafficking protein 3
Gene Alias:	C15orf22|P24B|p24g4|p24gamma4|p26
Gene Type:	protein-coding
CpG%:	0.141361
GC%:	0.744792
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TMED3 p2@TMED3 p3@TMED3 p4@TMED3
Sample		p1@TMED3	p2@TMED3	p3@TMED3	p4@TMED3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	79.28	27.47	7.40	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	85.78	37.83	3.64	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	79.67	28.55	6.17	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	73.39	28.90	5.20	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	73.79	25.87	4.72	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	62.02	27.52	5.23	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	95.00	33.34	8.93	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	90.35	31.00	5.09	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	91.68	34.84	6.41	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	63.18	22.03	5.80	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	69.53	27.49	4.45	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	64.24	18.70	2.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	27.24	33.37	4.51	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	24.36	25.26	3.61	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	27.44	32.05	4.83	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	26.91	26.16	5.53	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	24.90	34.51	4.37	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	24.04	35.85	5.91	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	24.53	29.86	4.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	27.98	33.10	4.66	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	32.88	30.21	4.68	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	27.27	32.28	4.14	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.44	28.31	3.23	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	28.39	30.82	3.88	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	29.15	29.41	3.87	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	32.60	39.56	6.01	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	31.87	34.07	2.20	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	31.36	33.48	4.95	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	31.66	35.37	4.85	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	28.41	30.22	4.89	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.40	38.94	2.93	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	29.70	39.27	3.32	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	33.98	37.99	5.28	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.42	35.13	4.45	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.24	31.79	5.98	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	30.85	34.49	6.32	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	30.45	32.09	4.91	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	32.04	31.43	6.45	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	34.57	43.76	8.10	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	35.05	39.13	6.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	31.05	33.64	5.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	25.47	33.52	4.54	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	30.37	33.11	5.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	28.67	33.57	5.59	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	32.32	32.12	4.42	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	30.71	34.43	4.19	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	30.23	31.43	3.60	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	35.17	39.64	6.56	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	42.13	38.30	5.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	27.50	28.11	6.67	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	38.12	30.74	3.89	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	32.24	32.47	6.67	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	33.00	37.26	5.32	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	36.12	26.84	3.98	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	11.75	6.71	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	28.47	19.29	3.67	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	39.87	32.09	5.19	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	43.36	29.55	7.71	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	27.98	21.37	3.77	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	46.53	24.68	7.76	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	45.42	29.72	7.85	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	23.88	7.96	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	33.30	13.25	4.42	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	41.26	19.17	9.10	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	51.47	24.49	6.74	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	58.50	34.61	6.83	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	53.06	32.73	4.46	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	51.60	23.46	7.51	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	51.00	28.48	5.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	61.25	32.48	7.73	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	59.31	35.16	3.97	0.61
Adipocyte - breast, donor1	11376-118A8	114.99	63.67	4.75	1.11
Adipocyte - breast, donor2	11327-117E4	52.46	33.37	3.05	0.48
Adipocyte - omental, donor1	11473-119C6	78.63	50.89	4.71	0.64
Adipocyte - omental, donor2	11474-119C7	92.69	62.79	9.72	2.24
Adipocyte - omental, donor3	11475-119C8	88.75	47.22	5.02	1.34
Adipocyte - perirenal, donor1	11476-119C9	199.69	120.58	17.23	3.83
Adipocyte - subcutaneous, donor1	11259-116F8	67.07	30.79	5.50	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	80.39	65.03	1.35	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	27.80	45.53	1.39	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	47.92	32.46	5.08	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	46.33	29.86	6.43	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	47.95	34.57	2.23	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	18.81	25.86	2.94	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	13.27	19.14	0.80	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	23.56	25.82	2.58	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	13.86	17.06	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	17.25	22.26	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	14.14	32.02	2.91	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	20.09	26.87	2.76	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.47	27.82	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.00	12.79	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	75.58	26.52	7.29	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	125.15	38.01	16.49	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	58.70	26.36	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	77.90	43.00	8.82	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	128.86	61.92	15.06	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	90.19	54.24	10.48	0.82
Anulus Pulposus Cell, donor1	11248-116E6	50.00	36.04	4.46	0.69
Anulus Pulposus Cell, donor2	11463-119B5	52.41	46.78	5.88	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	60.65	30.55	8.54	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	59.04	31.26	8.25	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	66.35	29.96	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	63.37	22.72	4.78	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	79.67	35.41	12.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	80.53	31.02	7.26	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	60.43	23.72	7.80	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	61.17	29.61	6.80	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	48.10	29.10	11.28	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	61.02	29.00	7.16	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	58.78	20.32	12.34	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	65.20	27.58	11.28	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	69.19	30.64	8.24	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	69.60	30.03	8.19	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	88.82	39.51	9.95	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	64.29	24.65	4.82	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	58.00	27.58	8.69	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	62.28	33.41	6.15	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	74.13	38.04	6.83	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	60.37	22.89	6.80	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	75.65	33.62	7.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	31.86	7.08	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	56.43	26.07	7.55	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	58.73	25.17	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	69.90	31.55	5.83	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	69.82	38.32	6.83	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	61.78	20.59	9.69	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	76.38	27.36	8.55	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	62.21	28.00	7.05	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	70.20	32.78	8.52	1.81
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	72.73	28.15	7.04	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	54.66	30.87	6.43	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	64.92	37.10	7.13	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	57.91	23.40	7.02	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	59.01	31.91	5.72	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	83.16	32.08	10.69	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	73.74	32.04	8.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	65.96	21.39	6.62	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	67.98	30.50	6.99	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	66.02	28.91	6.90	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	58.64	27.94	6.99	1.69
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	68.44	35.38	8.41	1.74
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	58.57	28.34	7.56	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	61.88	24.75	6.44	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	106.55	25.48	16.21	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	86.62	38.03	12.68	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	59.18	25.94	6.22	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	81.83	31.29	8.42	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	64.88	21.87	6.56	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	62.07	33.33	9.66	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	61.21	15.30	7.65	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	96.86	40.42	8.64	3.05
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	60.49	38.81	9.50	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	74.97	28.76	7.65	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	70.27	23.42	9.56	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	63.86	29.71	6.65	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	74.76	36.62	10.68	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	81.42	31.02	9.97	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	64.35	23.83	8.74	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	70.87	36.34	7.27	1.09
Astrocyte - cerebellum, donor1	11500-119F6	50.97	38.44	6.02	0.25
Astrocyte - cerebellum, donor2	11580-120F5	68.64	37.66	8.22	1.71
Astrocyte - cerebellum, donor3	11661-122F5	52.44	39.01	6.92	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	24.05	23.70	2.09	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	26.69	19.25	2.59	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	29.53	19.99	5.22	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	36.47	21.33	2.64	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	36.33	26.94	1.63	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	29.25	24.35	2.16	0.11
Basophils, donor1	12241-129G9	6.80	11.77	0.78	0.00
Basophils, donor2	12242-129H1	10.10	17.32	0.72	0.00
Basophils, donor3	12243-129H2	18.52	22.93	1.47	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	58.64	51.96	6.04	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	64.01	61.26	8.69	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	50.21	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	94.78	40.80	7.53	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	80.06	34.94	3.95	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	58.49	35.93	4.84	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	39.41	47.33	4.14	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	14.43	7.01	6.29	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	38.89	13.51	11.41	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	72.91	49.88	10.55	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	41.37	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	10.14	12.96	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	5.20	10.02	0.74	0.00
CD14+ Monocytes, donor3	11381-118B4	9.22	13.61	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	5.94	22.64	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	8.72	21.61	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.59	16.11	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	4.05	10.12	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	1.51	10.26	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	3.55	6.63	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.35	6.86	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.21	7.45	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3.97	6.94	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.50	6.46	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.10	6.94	0.53	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	4.35	10.66	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	4.21	7.73	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.39	11.09	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	6.66	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.87	10.26	0.74	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.39	7.38	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.75	7.08	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.52	6.86	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.71	4.07	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.06	5.24	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.38	6.72	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.88	7.15	0.52	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.31	6.31	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.02	7.16	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.11	5.64	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	0.88	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.53	8.37	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.35	11.52	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	4.96	10.78	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.60	7.78	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.39	5.56	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.64	4.64	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	15.91	29.43	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	17.56	33.96	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	13.21	29.24	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	14.17	22.11	0.47	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	13.27	21.31	0.70	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	7.36	14.27	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	16.59	45.17	1.02	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	13.61	36.67	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	10.95	40.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	36.58	26.42	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	25.76	24.41	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	23.82	33.14	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	23.99	26.12	6.40	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.95	24.66	2.14	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	17.55	23.87	2.81	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	33.73	28.24	1.57	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	29.00	21.09	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	7.40	16.44	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	10.88	13.78	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	9.09	17.67	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	4.85	7.27	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	7.19	14.78	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	44.18	45.18	5.02	0.00
CD34+ Progenitors, donor2	11625-122B5	20.23	24.72	8.99	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	56.36	39.08	10.52	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	71.70	43.97	13.30	1.58
CD4+ T Cells, donor1	11225-116C1	12.14	16.78	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	17.15	22.66	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	10.98	11.59	1.52	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	34.97	25.01	3.32	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	33.91	30.55	3.14	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	30.18	38.81	2.01	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	28.45	28.92	3.32	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	23.88	41.44	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	39.55	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	27.02	27.17	2.60	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	29.15	36.77	2.37	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	25.15	27.24	2.26	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	22.86	23.31	2.69	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	23.41	38.78	3.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	14.52	18.92	2.64	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	21.50	28.25	1.69	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.27	28.88	2.29	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	26.06	37.09	3.68	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	21.21	23.93	2.18	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	28.94	39.12	3.22	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	5.38	37.66	5.38	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	31.15	29.30	4.26	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	27.94	34.23	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	26.69	26.69	3.15	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	26.80	25.28	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	27.73	31.19	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	14.82	22.23	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	30.19	46.52	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	24.93	47.08	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	18.15	58.62	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	21.88	31.85	3.88	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	23.80	28.71	1.96	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	26.18	41.58	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	21.49	39.39	1.07	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	33.24	48.47	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	15.71	18.66	2.62	0.00
CD8+ T Cells, donor2	11307-117C2	15.77	18.77	1.50	0.38
CD8+ T Cells, donor3	11383-118B6	16.16	16.92	1.26	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	35.79	18.35	2.98	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	33.31	16.06	3.59	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	33.10	16.69	3.01	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	27.62	19.21	1.80	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	31.92	22.32	1.92	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	28.20	17.96	3.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	43.89	18.03	1.96	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	34.48	19.48	3.42	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	36.35	18.76	2.35	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	36.23	13.58	3.32	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	38.35	12.78	2.91	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	38.90	14.12	4.26	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	18.82	7.00	2.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	22.77	11.84	1.82	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	15.66	8.95	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	44.66	18.37	5.04	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	34.53	16.98	2.88	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	27.81	15.56	4.48	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	43.42	19.96	2.22	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	39.98	16.92	2.15	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	34.62	24.04	3.85	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	30.21	13.77	4.21	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	37.44	14.19	3.94	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.99	16.64	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	30.51	7.23	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.88	9.09	2.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	13.02	10.02	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	29.24	21.93	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	54.84	38.04	5.43	0.49
Cardiac Myocyte, donor3	11686-122I3	45.78	21.78	6.73	1.16
Chondrocyte - de diff, donor1	11261-116G1	70.72	30.85	5.55	1.73
Chondrocyte - de diff, donor2	11338-117F6	53.66	51.53	5.33	0.36
Chondrocyte - de diff, donor3	11410-118E6	52.11	41.64	5.12	0.34
Chondrocyte - re diff, donor2	11339-117F7	102.95	46.55	11.64	0.00
Chondrocyte - re diff, donor3	11411-118E7	102.72	48.53	11.73	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	37.87	29.95	5.05	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	56.65	26.29	7.70	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	61.68	26.73	8.23	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	16.69	34.11	1.01	0.09
Corneal Epithelial Cells, donor1	11526-119I5	39.74	44.35	3.73	0.22
Corneal Epithelial Cells, donor2	11606-120I4	46.64	55.74	2.28	1.14
Corneal Epithelial Cells, donor3	11687-122I4	41.16	27.35	4.09	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	36.98	37.81	1.82	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	38.48	43.21	1.89	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	31.06	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.00	33.15	1.30	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	48.85	24.60	3.42	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	73.12	39.83	4.57	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	59.53	37.75	4.84	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	69.04	31.19	6.50	2.00
Endothelial Cells - Aortic, donor1	11263-116G3	81.56	35.21	9.39	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	80.60	37.05	11.31	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	77.06	38.93	8.65	3.15
Endothelial Cells - Artery, donor1	11264-116G4	102.97	40.72	9.89	1.16
Endothelial Cells - Artery, donor2	11341-117F9	83.05	35.29	5.65	0.24
Endothelial Cells - Artery, donor3	11413-118E9	87.65	34.71	7.01	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	57.19	26.82	6.21	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	52.94	20.69	3.96	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	44.54	15.79	3.95	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	60.32	27.93	5.65	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	95.80	42.17	9.37	3.64
Endothelial Cells - Microvascular, donor3	11414-118F1	33.60	23.54	5.53	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	96.83	35.21	10.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	83.34	44.03	7.34	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	80.76	25.35	5.09	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	59.10	19.99	3.91	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	70.59	25.04	6.23	0.37
Endothelial Cells - Vein, donor1	11267-116G7	106.93	23.89	14.79	1.14
Endothelial Cells - Vein, donor2	11344-117G3	104.78	43.31	12.57	2.10
Endothelial Cells - Vein, donor3	11416-118F3	85.88	29.99	10.21	1.26
Eosinophils, donor1	12244-129H3	30.49	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	51.06	27.61	4.64	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	74.89	60.32	6.24	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	65.08	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	80.87	37.77	9.44	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	102.04	59.01	10.84	2.08
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	57.74	15.28	2.38	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	80.77	26.80	3.40	1.09
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	40.26	31.93	7.64	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	64.34	32.70	5.80	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	82.47	95.65	11.07	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	55.81	28.57	4.98	0.33
Fibroblast - Cardiac, donor1	11268-116G8	62.15	32.21	8.17	2.72
Fibroblast - Cardiac, donor2	11345-117G4	100.81	34.87	13.64	0.76
Fibroblast - Cardiac, donor3	11417-118F4	107.56	39.27	14.98	1.58
Fibroblast - Cardiac, donor4	11452-119A3	38.80	23.04	2.73	0.61
Fibroblast - Cardiac, donor5	11456-119A7	56.98	27.41	5.20	0.63
Fibroblast - Cardiac, donor6	11460-119B2	57.45	23.50	2.88	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	93.39	41.81	9.11	1.88
Fibroblast - Choroid Plexus, donor2	11572-120E6	74.21	37.10	10.79	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	77.63	33.69	8.79	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	47.51	28.14	5.07	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	49.69	37.48	3.90	0.51
Fibroblast - Dermal, donor1	11269-116G9	50.24	35.22	3.99	0.23
Fibroblast - Dermal, donor2	11346-117G5	62.26	34.90	5.66	0.94
Fibroblast - Dermal, donor3	11418-118F5	50.29	32.88	2.90	0.73
Fibroblast - Dermal, donor4	11450-119A1	39.91	17.18	2.60	0.23
Fibroblast - Dermal, donor5	11454-119A5	42.39	19.71	2.79	0.52
Fibroblast - Dermal, donor6	11458-119A9	50.35	18.35	4.39	0.16
Fibroblast - Gingival, donor1	11237-116D4	42.69	25.82	3.75	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	64.19	35.63	6.81	0.26
Fibroblast - Gingival, donor2	11318-117D4	51.79	20.56	4.74	0.92
Fibroblast - Gingival, donor3	11394-118C8	26.59	25.33	2.71	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	52.98	29.09	6.23	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	48.98	28.37	7.22	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	47.86	27.28	4.99	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	42.06	23.53	4.73	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	45.17	20.47	2.12	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	61.86	33.20	6.00	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	65.45	26.86	3.27	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	59.89	20.73	5.70	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	77.18	42.26	8.66	0.44
Fibroblast - Lung, donor1	11270-116H1	59.81	39.42	6.80	0.00
Fibroblast - Lung, donor2	11347-117G6	26.86	19.40	2.98	1.49
Fibroblast - Lung, donor3	11419-118F6	45.58	26.80	5.70	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	95.80	40.82	10.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	15.38	5.59	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	68.01	35.26	7.28	0.84
Fibroblast - Mammary, donor1	11540-120B1	80.38	23.14	4.06	1.62
Fibroblast - Mammary, donor2	11620-122A9	107.84	43.94	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	89.34	53.61	11.91	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	40.73	22.89	3.10	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	35.80	17.14	3.34	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	33.35	19.28	2.75	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	44.27	27.10	5.34	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	65.88	36.18	7.29	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	48.83	25.17	7.07	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	68.42	31.17	7.30	0.88
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	55.88	30.68	5.08	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	56.13	19.38	4.01	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	56.54	30.84	5.54	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	30.76	48.02	9.53	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	55.59	55.59	9.06	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	65.43	46.71	3.74	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	104.10	75.82	13.84	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	75.46	37.46	6.91	1.30
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	34.42	36.44	8.35	0.00
Fibroblast - skin normal, donor1	11553-120C5	102.38	57.10	12.96	1.48
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	37.49	53.13	7.02	0.60
Fibroblast - skin normal, donor2	11561-120D4	59.47	32.65	6.63	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	38.99	34.15	6.65	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	52.69	37.69	4.81	1.24
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	62.91	48.55	4.79	1.71
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	91.63	90.32	17.41	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	83.09	41.76	8.95	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	60.56	34.58	6.58	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	47.83	25.72	6.59	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.96	66.24	6.10	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	66.22	29.64	9.53	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	67.40	21.60	7.81	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	50.59	15.84	5.11	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	46.70	22.97	11.48	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	53.60	29.99	7.66	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	53.34	26.24	9.70	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	28.13	18.75	8.82	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	26.49	18.49	8.22	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	41.01	18.43	8.32	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	30.40	22.20	5.55	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	28.70	19.57	6.52	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	49.09	18.57	8.84	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	39.85	16.53	8.62	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	37.44	16.01	7.14	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	27.94	11.55	4.30	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	45.35	14.00	7.19	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	37.79	12.46	7.34	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	21.96	10.78	3.66	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	38.56	17.57	5.02	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	35.13	15.70	4.36	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	31.04	12.68	4.37	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	56.44	26.89	10.64	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	42.92	22.41	3.97	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	32.17	16.09	5.81	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	43.55	26.41	8.67	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	54.46	20.36	4.92	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	46.20	20.93	8.07	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	57.33	28.30	7.39	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	49.70	31.94	8.20	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	52.89	26.22	8.74	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	56.49	20.13	7.49	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.27	21.64	9.19	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	58.80	30.53	9.90	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	51.07	24.33	8.30	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	60.87	25.68	5.34	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	49.38	29.10	9.70	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	70.72	29.64	9.59	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	54.14	23.02	8.43	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	77.93	36.56	11.87	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	59.98	29.28	8.34	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	59.79	24.52	8.07	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	63.25	31.02	5.47	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	64.19	24.25	5.96	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	71.79	36.67	8.56	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	58.92	25.53	8.14	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	59.35	29.35	7.41	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	75.41	31.02	8.82	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	53.25	26.32	8.26	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	83.29	24.48	9.20	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	80.78	31.17	10.30	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	69.50	32.81	10.14	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	72.15	31.80	9.65	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	39.67	23.80	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	71.10	24.01	10.16	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	75.86	30.06	9.89	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	26.43	20.08	3.81	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	38.42	14.53	7.96	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	39.14	14.18	5.08	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	51.15	14.32	7.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	66.97	20.65	18.78	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	57.36	26.00	14.41	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	35.51	16.14	9.22	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	32.17	32.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	52.99	24.76	13.15	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	68.99	17.65	19.25	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	46.95	20.87	12.17	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	42.64	21.81	10.74	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	35.83	17.30	10.71	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	10.00	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	42.79	22.37	14.82	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	45.43	16.34	11.44	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	24.33	21.81	4.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	52.16	27.99	9.86	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	48.23	25.47	13.25	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	52.20	27.15	12.53	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	59.56	32.07	11.45	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	56.53	26.64	9.77	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	60.99	16.94	8.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	53.02	17.40	8.70	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	37.51	18.18	8.28	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	89.56	42.15	26.34	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	51.13	23.45	16.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	50.85	23.47	15.97	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	79.59	32.77	17.39	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	78.21	33.13	10.02	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	71.55	27.04	11.30	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	94.42	22.36	4.97	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	81.63	40.58	16.04	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	84.49	34.40	10.86	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	78.34	42.22	12.21	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	78.97	33.10	17.55	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	84.86	38.98	19.24	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	136.93	53.12	20.07	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	113.77	61.85	15.75	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	143.08	37.74	17.99	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	72.05	33.91	8.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	50.14	28.65	7.76	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	62.60	28.63	12.62	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	106.14	61.63	13.70	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	79.84	48.65	11.23	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	77.59	67.47	5.62	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	36.16	40.28	3.49	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	53.89	45.95	3.76	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	72.64	42.47	7.66	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	69.04	38.15	4.90	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	65.98	45.50	5.23	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	77.06	39.68	6.45	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	74.57	39.54	7.09	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	63.51	40.90	6.24	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	75.84	42.09	7.60	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	70.51	40.83	6.86	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	58.31	43.89	4.49	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	94.02	27.98	12.87	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	96.08	31.16	5.19	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	60.81	29.08	10.58	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	74.78	35.98	6.35	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	97.35	50.86	14.53	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	51.75	18.71	5.42	0.17
Hepatocyte, donor1	11523-119I2	3.63	9.68	1.21	0.00
Hepatocyte, donor2	11603-120I1	6.46	10.77	0.00	0.00
Hepatocyte, donor3	11684-122I1	8.59	9.82	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	26.76	12.40	13.71	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	42.47	14.33	12.58	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	71.76	32.66	9.33	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	41.39	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	46.73	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	54.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	30.46	18.00	5.54	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	32.53	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	23.74	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	46.13	15.38	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	41.14	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	30.86	42.23	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	38.35	25.01	5.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	25.41	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	55.59	27.79	5.29	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	27.72	34.37	4.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	36.67	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	39.05	24.56	7.56	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	29.39	18.56	12.37	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	34.89	22.61	9.69	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	51.52	35.42	4.83	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	23.90	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.93	32.60	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	46.18	24.77	9.24	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	43.40	20.09	12.06	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	41.55	23.08	5.54	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	41.07	22.19	6.61	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	38.09	30.84	3.63	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	49.50	25.83	4.30	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	38.11	35.57	7.62	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	38.90	21.04	4.46	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	47.39	41.92	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	47.41	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	37.13	23.56	6.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	26.55	6.64	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	104.24	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	39.20	24.38	7.10	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	50.92	36.88	7.02	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	47.15	22.00	6.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	51.46	34.77	4.17	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	26.56	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	25.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	36.62	29.65	6.10	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	38.25	4.50	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	31.36	10.45	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	26.67	36.27	7.47	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	40.18	19.40	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	39.89	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	45.10	23.01	3.68	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	54.46	12.10	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	49.67	18.63	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	24.32	27.49	4.23	1.06
Keratinocyte - epidermal, donor1	11272-116H3	42.92	20.48	2.77	0.24
Keratinocyte - epidermal, donor2	11349-117G8	55.05	30.45	7.03	0.59
Keratinocyte - epidermal, donor3	11421-118F8	39.66	26.69	2.65	0.85
Keratinocyte - oral, donor1	11251-116E9	42.57	34.28	2.84	0.68
Keratocytes, donor1	11527-119I6	34.73	24.41	2.41	0.00
Keratocytes, donor2	11607-120I5	46.87	30.47	3.52	0.00
Keratocytes, donor3	11688-122I5	26.28	25.49	3.16	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	19.78	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	42.07	16.18	5.39	0.00
Lens Epithelial Cells, donor2	11609-120I7	34.71	29.99	2.54	0.58
Lens Epithelial Cells, donor3	11690-122I7	100.20	36.13	11.00	1.72
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	47.08	26.09	4.39	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	40.74	24.00	3.63	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	40.45	25.50	5.51	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	41.94	30.11	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	45.07	25.53	3.78	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	42.80	21.13	4.64	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	37.76	18.06	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	56.88	23.26	3.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	35.89	22.24	3.94	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	42.72	18.19	5.93	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	44.59	21.71	3.30	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	43.51	27.40	2.96	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	33.80	27.87	3.14	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	45.32	21.94	3.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	37.08	26.37	3.16	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	41.27	21.56	3.08	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	50.50	20.89	4.05	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	36.42	25.25	4.39	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	42.13	25.01	2.63	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	56.52	26.36	4.69	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	41.82	27.13	3.98	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.37	26.19	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	40.66	22.35	4.04	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	36.94	22.56	3.48	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	41.47	19.18	3.63	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	38.53	19.47	4.61	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	36.99	25.26	4.51	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	46.78	19.26	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	34.62	22.95	4.52	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	34.78	26.93	4.24	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	43.13	15.51	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	44.99	23.82	3.31	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	35.06	28.25	4.96	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	45.54	22.21	4.81	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	47.93	23.47	3.95	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	37.67	24.34	4.12	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	40.53	22.19	3.86	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	47.17	17.35	4.87	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	32.61	25.05	5.32	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	44.80	25.24	3.91	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	49.45	29.57	5.82	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	41.86	30.03	5.91	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	52.64	25.78	6.45	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	37.57	24.17	4.25	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	42.14	28.49	5.41	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	43.93	21.66	3.22	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	45.85	18.70	2.82	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	29.24	22.68	3.28	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	58.92	81.58	20.39	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	47.56	100.49	7.67	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	49.73	75.71	8.16	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	52.47	91.40	12.27	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	51.34	90.03	12.66	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	50.43	87.79	6.54	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	53.59	73.68	9.79	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	39.25	66.61	8.33	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	59.94	94.10	10.18	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	48.86	78.23	7.85	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	39.62	78.78	9.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	58.53	84.81	10.16	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	47.24	88.84	8.22	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	44.11	75.86	9.53	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	35.98	83.95	4.66	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	51.45	72.33	9.17	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	55.50	80.04	11.21	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	53.28	71.04	11.15	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	59.52	81.60	17.18	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	54.63	92.14	13.86	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	46.23	75.18	8.95	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	59.98	82.68	10.09	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	56.67	79.34	6.18	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	59.51	85.35	6.10	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	57.99	91.77	12.26	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	49.79	82.44	12.72	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	43.48	70.34	10.96	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	52.74	85.56	7.01	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	67.93	99.01	5.76	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	56.41	92.10	13.82	3.07
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	50.95	71.90	6.79	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	59.07	79.59	12.31	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	51.97	66.43	9.94	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	45.96	84.02	10.05	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	44.81	94.11	8.22	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	50.54	69.49	10.78	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	55.14	73.66	9.05	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	48.81	76.21	13.70	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	48.64	76.96	7.66	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	48.87	100.15	13.27	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	47.64	73.23	6.40	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	48.81	71.49	9.97	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	52.60	83.73	11.81	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	53.87	68.01	10.10	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	53.34	75.56	9.26	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	68.61	91.87	8.14	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	48.66	88.85	11.64	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	48.82	92.84	10.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	53.79	93.04	12.36	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	61.32	82.02	8.43	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	43.90	90.76	6.91	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	45.16	68.69	6.59	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	56.82	85.48	10.56	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	50.02	80.21	9.46	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	48.19	74.01	10.33	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	51.66	78.83	10.69	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	40.28	73.51	12.12	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	39.58	85.77	5.28	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	53.45	90.81	6.23	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	45.94	64.32	6.56	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	53.11	93.93	8.39	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	59.62	90.98	13.25	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	54.00	75.99	7.71	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	56.21	84.05	11.14	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	58.64	95.64	15.38	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	57.64	75.53	9.94	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	54.08	85.07	7.90	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	63.64	69.86	13.83	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	64.60	74.86	11.02	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	60.94	99.67	12.39	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	58.05	90.70	15.12	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	57.04	83.34	7.29	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	57.04	76.23	10.66	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	65.51	91.95	12.64	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	49.37	56.57	12.86	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	64.37	75.69	10.61	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	64.13	89.66	8.51	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	49.92	71.56	9.15	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	53.25	83.79	14.09	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	67.23	100.63	11.27	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	52.04	81.78	12.08	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	55.53	88.31	8.03	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	81.27	88.75	14.44	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	55.77	73.55	10.91	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	64.24	78.01	10.10	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	80.02	88.02	12.45	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	55.28	74.08	12.54	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	47.55	63.65	9.20	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	83.17	80.43	13.13	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	49.44	65.93	11.58	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	84.49	91.76	9.62	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	78.91	70.95	13.93	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	64.44	74.83	20.79	0.00
Macrophage - monocyte derived, donor1	11232-116C8	13.90	30.31	1.60	0.00
Macrophage - monocyte derived, donor2	11313-117C8	49.18	38.90	2.20	0.55
Macrophage - monocyte derived, donor3	11389-118C3	31.85	39.32	1.97	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	103.55	30.80	15.40	0.53
Mallassez-derived cells, donor2	11929-125I3	89.68	25.83	11.73	0.32
Mallassez-derived cells, donor3	11930-125I4	66.85	20.15	6.39	0.42
Mammary Epithelial Cell, donor1	11273-116H4	24.91	28.10	3.19	0.20
Mammary Epithelial Cell, donor2	11350-117G9	32.72	27.51	2.03	0.00
Mammary Epithelial Cell, donor3	11422-118F9	41.16	32.43	4.99	0.75
Mast cell - stimulated, donor1	11487-119E2	14.91	9.49	1.36	0.00
Mast cell, donor1	11563-120D6	13.09	20.55	1.84	0.32
Mast cell, donor2	11565-120D8	4.16	11.00	0.30	0.00
Mast cell, donor3	11566-120D9	4.95	11.03	0.68	0.23
Mast cell, donor4	11567-120E1	0.71	4.61	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	22.84	24.17	2.11	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	22.76	23.35	3.50	0.58
Mast cell, expanded, donor5	11939-126A4	15.26	27.99	1.15	0.00
Mast cell, expanded, donor8	11941-126A6	12.22	28.79	1.34	0.00
Melanocyte - dark, donor1	11502-119F8	63.88	26.37	7.86	0.70
Melanocyte - dark, donor2	11582-120F7	53.64	33.57	4.85	0.00
Melanocyte - dark, donor3	11663-122F7	44.70	34.12	4.93	0.36
Melanocyte - light, donor1	11274-116H5	31.50	37.61	4.00	0.00
Melanocyte - light, donor2	11351-117H1	42.31	58.69	6.14	0.00
Melanocyte - light, donor3	11423-118G1	40.76	32.09	5.20	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	56.02	34.99	10.20	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	85.52	49.22	4.30	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	39.37	36.16	3.75	0.27
Meningeal Cells, donor1	11493-119E8	51.48	25.06	5.21	0.37
Meningeal Cells, donor2	11573-120E7	50.62	25.53	6.60	0.00
Meningeal Cells, donor3	11654-122E7	35.21	18.66	4.24	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	58.74	21.10	5.13	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	113.11	44.88	13.08	1.51
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	82.79	82.79	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	119.04	56.25	5.23	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	70.33	30.14	5.02	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	39.81	36.85	7.20	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	42.22	38.70	8.04	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	61.09	38.02	7.03	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	60.64	34.34	6.58	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	69.36	28.64	6.96	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	77.84	50.28	7.62	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	68.40	51.30	7.43	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	56.84	36.05	5.13	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	104.16	50.15	10.98	2.08
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	93.42	37.37	9.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	77.49	35.22	7.68	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	86.48	32.25	4.96	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	68.80	35.03	7.19	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	69.67	34.83	5.81	0.73
Mesothelial Cells, donor1	11247-116E5	64.97	42.16	3.18	0.00
Mesothelial Cells, donor2	12156-128G5	83.58	50.05	5.51	0.00
Mesothelial Cells, donor3	11402-118D7	24.06	21.82	2.02	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	37.81	21.61	5.40	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	44.33	37.19	3.20	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	56.54	38.87	5.89	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	6.91	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	41.84	26.04	4.34	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	43.35	30.49	3.73	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	16.21	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	49.80	37.79	3.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	51.67	28.39	4.19	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	42.88	31.50	3.45	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	51.08	37.22	5.15	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	8.55	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	35.40	26.55	7.96	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	64.59	45.21	5.32	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	15.79	5.26	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	36.50	31.62	2.76	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	33.15	11.97	3.68	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	33.98	23.84	2.98	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	15.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	40.90	29.36	1.76	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	34.46	29.71	4.52	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	21.56	10.50	2.21	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	33.85	32.00	4.37	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	40.17	33.02	3.16	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	25.07	16.71	2.04	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	37.33	28.10	2.15	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	31.79	22.45	5.56	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	10.32	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	29.35	21.68	2.63	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	27.88	14.19	2.53	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	6.63	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	21.20	15.76	1.90	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	32.35	22.94	4.71	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	5.45	3.27	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	40.85	27.39	4.32	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	41.62	33.62	3.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	6.86	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	37.04	26.53	5.51	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	12.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	34.60	25.40	2.19	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	18.76	5.52	6.62	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	4.48	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	29.25	29.01	1.98	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	29.23	22.27	4.18	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	2.21	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	39.32	24.27	1.37	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.50	11.82	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.78	8.88	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	33.67	30.86	2.52	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.03	27.85	2.49	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	10.49	6.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	28.96	22.32	1.81	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	37.57	34.23	2.09	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	18.47	14.78	2.77	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	35.85	31.87	5.69	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.27	12.44	1.11	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	29.54	24.62	1.81	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	30.46	28.31	4.29	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.70	6.99	1.27	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	21.35	18.68	2.14	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	30.83	37.12	2.10	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.71	10.45	0.57	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	27.39	36.95	1.91	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	31.40	32.06	3.32	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.13	12.13	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	25.57	25.29	1.42	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	40.56	43.51	1.97	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	8.47	11.08	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	26.76	32.64	1.18	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	35.75	35.18	1.73	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.84	23.90	1.24	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	36.93	1.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	60.27	48.97	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	39.21	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.03	38.11	1.97	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	25.25	35.77	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	20.36	39.54	1.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	8.38	27.94	1.86	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.51	23.66	1.88	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.84	35.16	1.60	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.10	31.33	1.02	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	30.21	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	19.42	24.92	2.20	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	23.33	26.45	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	14.96	19.77	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	30.91	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	25.25	46.46	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.93	20.24	1.26	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	9.53	14.98	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	1.27	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	6.48	4.05	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	7.55	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	16.31	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	28.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	73.68	31.02	9.26	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	44.94	22.99	8.36	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	39.38	18.69	6.01	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	33.81	13.36	2.50	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	20.73	10.08	0.76	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	62.24	23.94	6.38	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	26.52	13.60	7.48	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	11.03	5.51	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	43.53	27.62	8.79	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	46.26	16.74	5.35	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	34.05	22.70	5.94	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	47.09	30.69	4.84	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	22.27	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	48.64	28.79	1.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	49.80	23.82	3.25	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	45.56	24.48	6.12	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	38.05	24.01	4.08	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	39.37	29.89	5.83	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	53.04	35.01	5.30	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	34.22	23.41	5.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.30	10.83	1.97	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	39.68	24.39	4.88	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	36.69	26.63	6.70	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	45.01	32.35	4.92	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	40.45	35.86	5.06	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	63.63	37.92	7.39	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	28.63	13.80	2.76	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	39.66	28.52	6.91	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	53.77	30.48	2.96	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	29.91	18.28	1.42	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	84.99	42.07	9.44	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	47.32	31.66	5.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	49.14	17.58	4.51	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	53.96	26.59	5.16	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	50.15	30.65	3.71	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	76.81	38.97	6.81	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	55.07	20.20	5.54	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	29.63	21.35	3.49	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	48.39	26.23	8.59	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	59.97	25.58	8.82	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	53.85	40.56	3.32	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	66.47	33.23	5.95	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	45.56	18.76	4.59	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	83.17	68.35	6.65	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	51.50	26.52	5.30	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	56.25	35.92	3.39	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	78.04	62.80	10.97	2.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	47.21	22.35	5.04	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	31.78	34.20	3.33	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	53.01	42.72	6.33	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	28.34	11.34	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	139.76	39.50	10.44	1.37
Myoblast, donor2	11322-117D8	94.74	38.36	7.86	0.77
Myoblast, donor3	11398-118D3	82.90	39.85	4.54	1.18
NK T cell leukemia cell line:KHYG-1	10777-110G3	33.86	21.31	12.11	0.88
Natural Killer Cells, donor1	11230-116C6	10.15	13.22	0.92	0.31
Natural Killer Cells, donor2	11311-117C6	19.30	15.08	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	13.80	11.60	1.66	0.00
Neural stem cells, donor1	11275-116H6	16.70	16.70	4.72	0.36
Neural stem cells, donor2	11352-117H2	19.26	13.48	3.85	0.00
Neurons, donor1	11494-119E9	21.62	19.34	1.14	0.00
Neurons, donor2	11574-120E8	23.34	20.70	2.64	0.22
Neurons, donor3	11655-122E8	26.31	24.66	8.22	0.82
Neutrophils, donor1	11233-116C9	0.00	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.61	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	48.21	38.00	4.75	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	53.07	31.91	8.47	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	56.96	40.71	6.62	0.80
Olfactory epithelial cells, donor1	11933-125I7	45.70	24.23	7.85	0.69
Olfactory epithelial cells, donor2	11934-125I8	43.28	25.04	6.37	0.43
Olfactory epithelial cells, donor3	11935-125I9	44.72	29.85	4.65	0.45
Olfactory epithelial cells, donor4	11936-126A1	64.09	46.17	4.87	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	43.93	24.67	4.81	1.20
Osteoblast - differentiated, donor1	11276-116H7	89.76	60.19	5.53	1.91
Osteoblast - differentiated, donor2	11353-117H3	105.17	69.73	8.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	80.69	85.66	10.55	0.62
Osteoblast, donor1	11277-116H8	149.31	60.59	16.81	4.69
Osteoblast, donor2	11354-117H4	56.19	12.64	7.73	2.11
Osteoblast, donor3	11426-118G4	121.75	46.03	13.86	1.96
Pancreatic stromal cells, donor1	11249-116E7	44.56	23.84	4.55	0.84
Pericytes, donor1	11491-119E6	71.32	47.96	8.12	0.33
Pericytes, donor2	11571-120E5	55.01	42.78	12.22	2.26
Pericytes, donor3	11652-122E5	114.54	32.55	10.78	1.22
Perineurial Cells, donor1	11499-119F5	66.46	28.48	6.78	1.92
Perineurial Cells, donor2	11579-120F4	45.18	28.34	4.69	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	12.43	11.16	1.27	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	8.57	12.98	0.73	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	8.67	12.04	1.55	0.00
Placental Epithelial Cells, donor1	11278-116H9	84.66	70.08	5.02	0.24
Placental Epithelial Cells, donor2	11355-117H5	217.34	92.04	14.42	3.33
Placental Epithelial Cells, donor3	11427-118G5	75.39	59.09	11.19	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	103.80	48.73	6.96	0.00
Preadipocyte - breast, donor1	11467-119B9	97.92	47.08	6.00	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	35.11	25.97	3.92	0.52
Preadipocyte - breast, donor2	11328-117E5	95.69	49.31	6.75	1.80
Preadipocyte - omental, donor1	11468-119C1	100.27	57.33	7.99	0.75
Preadipocyte - omental, donor2	11329-117E6	71.58	49.32	3.49	2.62
Preadipocyte - omental, donor3	11403-118D8	114.17	40.83	8.31	1.29
Preadipocyte - perirenal, donor1	11469-119C2	205.71	89.57	11.81	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	128.07	37.78	8.29	2.15
Preadipocyte - subcutaneous, donor2	11356-117H6	55.43	30.10	5.67	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	107.11	51.43	13.28	2.38
Preadipocyte - visceral, donor1	11280-116I2	70.33	34.74	4.19	0.47
Preadipocyte - visceral, donor2	11357-117H7	74.09	42.80	5.52	0.46
Preadipocyte - visceral, donor3	11429-118G7	90.49	39.50	8.05	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	28.81	10.56	13.58	0.00
Prostate Epithelial Cells, donor2	11331-117E8	57.96	20.04	8.26	0.81
Prostate Epithelial Cells, donor3	11404-118D9	19.11	18.00	1.22	0.18
Prostate Stromal Cells, donor1	11254-116F3	70.73	28.82	8.54	0.57
Prostate Stromal Cells, donor2	11332-117E9	81.22	34.07	9.32	0.72
Prostate Stromal Cells, donor3	11405-118E1	56.52	31.70	6.88	1.36
Renal Cortical Epithelial Cells, donor1	11516-119H4	44.53	44.16	4.74	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	31.26	23.70	2.01	0.21
Renal Epithelial Cells, donor1	11517-119H5	66.45	43.62	3.55	0.51
Renal Epithelial Cells, donor2	11597-120H4	55.48	32.01	4.27	0.00
Renal Epithelial Cells, donor3	11678-122H4	36.52	29.01	2.22	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	87.83	38.81	9.53	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	80.99	31.53	9.43	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	52.62	28.86	5.33	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	86.51	42.59	9.32	1.33
Renal Mesangial Cells, donor1	11518-119H6	61.40	29.71	5.28	1.10
Renal Mesangial Cells, donor2	11598-120H5	37.62	37.62	8.15	0.63
Renal Mesangial Cells, donor3	11679-122H5	52.43	23.58	5.55	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	60.13	34.36	2.42	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	48.07	32.47	2.95	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	52.45	23.53	4.05	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	47.71	24.11	2.85	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	78.74	36.10	6.54	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	67.92	25.73	3.09	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	35.88	31.61	4.27	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	16.84	18.84	1.34	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	34.84	46.46	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	19.81	16.51	1.65	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	13.92	20.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	29.78	22.23	3.38	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	34.06	26.51	2.88	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	42.94	35.25	4.46	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	32.38	19.23	2.98	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	37.88	26.69	3.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	41.60	28.89	3.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	32.31	20.54	2.60	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	31.62	21.18	3.33	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	46.95	40.86	2.69	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	35.86	28.12	3.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	33.48	21.36	2.90	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	40.27	24.12	4.65	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	28.68	22.37	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	31.58	20.22	2.79	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	37.21	27.43	4.32	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	28.00	20.04	2.92	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	30.66	22.39	3.80	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	40.10	29.60	4.01	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	33.85	24.67	3.10	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	28.87	22.42	3.36	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	37.94	29.91	3.59	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	28.81	22.43	1.82	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	33.48	25.02	4.41	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	43.25	31.03	4.30	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	41.51	36.09	2.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	35.12	22.42	3.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	50.28	31.34	3.74	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	38.57	22.81	3.94	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	39.60	28.31	3.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	38.43	31.33	3.97	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	40.78	26.51	4.31	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	28.27	18.39	2.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	40.29	26.22	4.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	36.62	28.37	1.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	31.82	22.63	3.57	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	41.21	25.28	3.45	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	27.95	23.18	2.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	37.29	25.30	3.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	30.12	26.12	1.87	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	33.05	25.44	4.01	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	32.62	27.38	3.33	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	27.01	24.18	3.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	27.22	23.73	3.48	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	30.05	23.41	3.84	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.55	22.36	4.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	28.15	22.89	2.81	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	23.73	25.33	3.78	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	35.90	32.25	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	28.93	28.33	2.41	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	39.13	33.93	3.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	46.13	38.64	5.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	34.24	31.29	3.78	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	49.73	46.53	5.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	39.66	31.85	3.61	0.60
Schwann Cells, donor1	11498-119F4	59.62	36.86	7.33	0.75
Schwann Cells, donor2	11578-120F3	27.22	13.61	3.40	0.00
Schwann Cells, donor3	11659-122F3	48.20	23.00	7.01	0.66
Sebocyte, donor1	11220-116B5	40.53	16.43	4.38	1.10
Sebocyte, donor2	11301-117B5	43.20	16.54	3.22	0.00
Sebocyte, donor3	11378-118B1	46.79	23.29	3.30	0.41
Sertoli Cells, donor1	11255-116F4	144.12	48.04	8.28	1.66
Sertoli Cells, donor2	11333-117F1	64.96	56.49	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	29.21	37.92	4.66	0.18
Skeletal Muscle Cells, donor2	11358-117H8	56.38	52.04	6.51	0.00
Skeletal Muscle Cells, donor3	11430-118G8	117.05	45.15	8.36	0.84
Skeletal Muscle Cells, donor4	11451-119A2	63.31	30.00	5.34	0.63
Skeletal Muscle Cells, donor5	11455-119A6	59.61	28.09	5.05	1.04
Skeletal Muscle Cells, donor6	11459-119B1	60.48	26.78	4.77	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	51.66	30.12	4.66	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	49.08	26.11	4.28	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	64.19	23.31	3.87	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	50.97	30.75	4.47	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	60.07	38.36	3.62	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	70.73	41.42	11.97	0.96
Skin - palm, donor1	10286-104F7	16.12	29.55	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	46.42	21.48	4.04	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	59.71	17.99	5.73	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	24.41	17.66	2.34	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	42.68	22.66	6.26	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	24.19	10.83	3.66	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	44.40	26.64	6.13	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	24.73	16.04	2.17	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	127.14	18.21	4.63	3.09
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	194.98	124.06	38.69	1.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	121.68	35.27	12.93	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	74.47	31.16	5.75	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	154.36	48.83	14.18	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	142.92	57.94	11.59	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	26.02	33.02	7.01	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	153.97	45.65	11.31	1.86
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	119.47	46.99	13.96	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	251.07	51.21	25.73	5.25
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	53.40	26.05	6.51	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	88.89	30.12	7.38	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	93.82	32.60	8.11	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	66.86	39.86	4.23	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.62	40.79	2.13	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	92.69	65.67	8.84	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	91.81	61.21	18.36	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	141.14	38.62	13.83	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	59.87	27.43	5.75	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	82.44	26.04	8.18	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	76.83	22.57	7.03	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	150.50	47.80	12.06	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	151.98	58.21	15.09	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	136.28	47.22	10.76	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	99.69	31.75	7.17	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	56.15	30.08	5.10	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	75.48	44.28	7.85	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	147.45	60.76	14.34	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	164.84	86.95	13.89	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	61.46	21.46	3.97	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	74.44	30.63	7.86	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	85.65	32.93	9.89	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	63.42	37.54	8.62	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	114.74	47.80	7.09	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	65.26	81.77	4.50	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	50.40	28.43	11.63	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	126.50	53.95	9.30	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	196.90	67.65	17.17	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	187.10	68.01	20.68	3.76
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	74.63	34.51	7.37	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	39.99	21.33	2.58	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	50.45	29.90	4.67	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	169.54	37.13	15.40	2.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	108.10	35.69	11.47	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	131.81	45.88	13.91	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	43.74	15.79	5.17	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	69.63	28.15	7.12	0.92
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	133.33	31.90	13.33	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	153.89	28.38	16.39	1.96
Smooth Muscle Cells - Uterine, donor1	11258-116F7	111.58	38.44	16.35	2.87
Smooth Muscle Cells - Uterine, donor3	11466-119B8	61.15	32.48	2.34	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	44.51	40.62	4.08	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	46.01	27.77	4.76	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	28.27	20.46	2.60	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	79.77	45.28	5.03	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	59.90	39.75	5.39	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	51.60	22.45	5.91	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	34.28	38.85	3.56	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	39.93	54.71	3.59	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	41.38	43.47	5.85	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	43.54	46.29	5.50	0.46
Synoviocyte, donor1	11291-117A4	79.28	35.52	7.91	0.50
Synoviocyte, donor2	11368-117I9	50.62	60.51	5.20	0.84
Synoviocyte, donor3	11440-118H9	41.11	56.30	3.80	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	82.19	27.16	8.22	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	51.53	23.78	7.93	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	73.17	26.16	6.71	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	50.61	26.95	3.44	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	54.12	28.22	5.03	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	50.97	30.92	10.88	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	20.42	21.65	2.09	0.00
Urethra, donor2	10319-105A4	21.58	35.97	1.80	0.00
Urothelial Cells, donor1	11520-119H8	57.12	31.08	4.25	1.59
Urothelial Cells, donor2	11600-120H7	38.85	26.04	2.40	0.00
Urothelial Cells, donor3	11681-122H7	66.01	38.96	3.44	0.46
Urothelial cells, donor0	11216-116B1	63.30	26.52	2.67	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	20.47	16.91	2.67	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	18.58	15.73	4.29	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	10.27	8.21	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	11.02	11.71	1.72	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	10.46	22.08	2.32	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	14.58	13.54	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	13.77	18.36	4.59	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	10.04	12.78	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	19.86	16.41	3.08	0.99
Wilms' tumor cell line:HFWT	10597-108E3	29.04	30.80	2.64	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	16.20	8.10	3.63	0.56
achilles tendon, donor2	10292-104G4	12.40	18.60	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	29.57	9.69	5.35	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	25.31	9.98	12.54	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	33.95	15.08	3.92	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	149.12	29.39	6.26	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	64.37	41.88	4.22	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	47.16	35.95	2.33	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.69	11.16	5.17	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	46.27	16.74	3.08	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	66.97	33.49	9.80	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	60.19	24.46	13.98	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	70.84	25.58	6.81	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	42.91	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	48.34	29.98	6.27	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	33.92	30.81	4.66	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	28.93	28.35	3.51	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.89	18.59	2.79	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	61.69	22.62	8.64	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	75.20	46.96	6.75	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	64.43	34.99	5.12	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	44.28	32.45	5.46	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	69.08	35.87	8.67	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	79.07	45.22	4.90	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	19.68	19.68	1.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	39.02	7.43	7.43	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	71.19	29.76	3.39	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	12.65	11.34	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	54.36	11.25	15.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	53.69	42.86	18.60	1.41
adipose tissue, adult, pool1	10010-101C1	7.76	14.27	0.78	0.16
adipose, donor1	10184-103D4	25.22	9.38	2.93	0.59
adipose, donor2	10185-103D5	24.74	21.09	5.68	0.81
adipose, donor3	10186-103D6	25.32	17.97	7.35	0.00
adipose, donor4	10187-103D7	21.67	8.67	8.67	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	22.41	43.40	1.10	0.16
adrenal gland, adult, pool1	10081-102A9	7.28	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	23.08	19.21	2.53	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	43.95	24.65	5.36	0.36
amniotic membrane cells, donor1	12235-129G3	103.64	159.28	9.51	0.23
amniotic membrane cells, donor2	12236-129G4	296.85	337.77	23.33	1.35
amniotic membrane cells, donor3	12237-129G5	54.50	141.11	3.83	0.29
amygdala - adult, donor10196	10167-103B5	7.11	11.86	1.19	0.00
amygdala, adult, donor10252	10151-102I7	5.88	16.63	1.01	0.20
amygdala, newborn, donor10223	10360-105E9	10.33	25.50	1.61	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	88.37	22.79	16.04	1.91
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	38.83	17.43	2.87	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	25.05	19.37	6.01	1.00
aorta, adult, pool1	10052-101G7	23.14	32.95	2.75	0.00
appendix, adult	10189-103D9	15.14	14.36	3.10	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	69.47	35.77	20.29	1.38
artery, adult	10190-103E1	1.36	16.30	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	38.39	29.70	5.79	0.14
b cell line:RPMI1788	10427-106D4	57.84	16.51	7.88	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	92.11	36.35	9.99	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	59.14	20.74	3.37	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	79.17	72.47	12.55	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	42.50	28.52	3.36	0.00
bladder, adult, pool1	10011-101C2	10.54	19.12	0.43	0.00
blood, adult, pool1	10053-101G8	6.64	8.86	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	44.53	29.97	2.57	0.00
bone marrow, adult	10192-103E3	26.99	23.62	4.72	0.00
brain, adult, donor1	10084-102B3	11.28	16.40	1.03	0.00
brain, adult, pool1	10012-101C3	7.57	17.04	0.56	0.00
brain, fetal, pool1	10085-102B4	13.36	32.06	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	27.09	23.46	10.57	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	42.56	12.48	19.47	0.75
breast, adult, donor1	10080-102A8	10.73	12.63	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	44.21	29.85	14.10	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	52.88	30.61	17.32	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	22.10	27.86	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	19.85	32.92	2.91	0.00
carcinoid cell line:NCI-H1770	10703-109H1	105.79	29.62	15.52	2.82
carcinoid cell line:NCI-H727	10735-110B6	60.71	44.63	16.52	1.09
carcinoid cell line:SK-PN-DW	10719-109I8	37.71	24.08	1.58	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	28.75	34.34	3.46	0.00
caudate nucleus - adult, donor10196	10177-103C6	6.91	14.97	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	4.52	22.09	0.67	0.17
caudate nucleus, adult, donor10258	10379-105H1	3.82	26.74	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	8.79	20.51	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	17.48	37.87	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	11.74	30.75	3.20	0.21
cerebellum, adult, pool1	10083-102B2	22.08	33.46	3.45	1.38
cerebellum, newborn, donor10223	10357-105E6	15.78	44.84	2.49	0.00
cerebral meninges, adult	10188-103D8	15.88	20.17	1.76	0.00
cerebrospinal fluid, donor2	10294-104G6	5.12	8.04	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	57.23	38.53	7.76	1.44
cervical cancer cell line:ME-180	10553-107I4	44.25	20.71	5.63	0.50
cervix, adult, pool1	10013-101C4	26.14	31.29	1.89	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	113.00	67.30	4.60	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	37.88	9.14	5.23	0.00
choriocarcinoma cell line:BeWo	10423-106C9	38.53	27.59	7.95	0.87
choriocarcinoma cell line:SCH	10785-110H2	23.04	27.85	2.46	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	53.60	42.69	6.88	0.24
chorionic membrane cells, donor1	12238-129G6	87.47	80.92	10.83	0.85
chorionic membrane cells, donor2	12239-129G7	127.07	46.43	25.26	2.29
chorionic membrane cells, donor3	12240-129G8	80.22	50.00	13.19	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	53.52	14.14	11.11	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	29.01	19.02	8.26	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	31.47	13.94	10.56	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	24.91	16.69	2.82	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	22.49	13.55	1.45	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	19.34	18.32	3.26	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	28.56	22.38	3.24	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	60.99	21.37	4.17	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	37.26	31.54	3.20	0.69
clear cell carcinoma cell line:TEN	10636-108I6	84.32	28.11	14.05	1.04
colon carcinoma cell line:CACO-2	10513-107D9	68.64	18.67	26.72	0.55
colon carcinoma cell line:COLO-320	10420-106C6	33.45	13.30	13.68	0.76
colon, adult, donor1	10082-102B1	29.75	36.89	7.14	0.00
colon, adult, pool1	10014-101C5	13.40	19.51	2.12	0.24
colon, fetal, donor1	10070-101I7	8.65	17.92	3.09	0.00
common myeloid progenitor CMP, donor1	12130-128D6	96.25	27.50	18.33	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	125.18	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	35.27	18.27	4.25	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	38.79	14.04	3.47	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	44.56	14.10	3.67	0.85
corpus callosum, adult, pool1	10042-101F6	10.39	28.86	0.77	0.22
cruciate ligament, donor2	10295-104G7	10.54	8.92	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	20.87	15.25	1.61	0.00
diencephalon, adult	10193-103E4	10.08	16.80	0.72	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	36.74	9.87	7.58	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	36.16	34.36	6.67	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	26.24	11.31	1.93	0.24
ductus deferens, adult	10196-103E7	75.75	56.81	11.96	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	44.65	12.96	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.93	37.52	8.09	0.74
dura mater, adult, donor1	10041-101F5	25.68	31.96	3.47	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	75.95	27.54	7.99	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	68.06	30.95	4.73	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	18.50	18.50	4.32	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	38.44	40.26	2.12	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	30.87	20.38	2.78	0.93
embryonic pancreas cell line:2C6	10603-108E9	23.64	14.45	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	45.25	17.43	5.03	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	32.80	38.97	1.81	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	33.77	38.76	1.77	0.32
epidermoid carcinoma cell line:A431	10426-106D3	23.23	24.45	4.89	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	52.02	15.18	12.98	0.99
epididymis, adult	10197-103E8	47.30	81.00	9.21	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	12.42	20.05	0.53	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	30.67	18.48	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	45.47	31.58	9.96	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	42.81	28.84	9.25	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	53.10	35.07	9.41	0.78
esophagus, adult, pool1	10015-101C6	37.69	36.53	3.50	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	33.69	32.44	2.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	9.66	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	2.10	10.52	0.00	0.00
eye - muscle medial, donor2	10299-104H2	4.46	17.86	0.00	0.00
eye - muscle superior, donor2	10297-104G9	8.03	16.05	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	18.95	5.83	0.00	0.00
eye, fetal, donor1	10054-101G9	30.76	23.14	4.58	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	37.70	22.18	3.21	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	39.89	18.52	0.95	0.95
frontal lobe, adult, pool1	10040-101F4	8.44	21.58	0.75	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	39.03	36.03	3.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	102.41	50.75	5.30	0.27
gall bladder, adult	10198-103E9	34.52	35.01	5.55	0.24
gamma delta positive T cells, donor1	11937-126A2	22.55	33.28	2.15	0.00
gamma delta positive T cells, donor2	11938-126A3	20.54	32.12	2.24	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.74	17.74	1.27	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	86.26	102.32	9.67	0.58
gastric cancer cell line:AZ521	10549-107H9	24.59	36.07	0.98	0.16
gastric cancer cell line:GSS	10560-108A2	44.85	77.79	6.41	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	16.91	18.05	3.43	0.00
giant cell carcinoma cell line:LU65	10487-107B1	29.60	18.93	3.21	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	21.83	25.47	1.40	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	67.09	58.86	17.21	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	23.33	24.28	1.69	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	24.72	19.10	1.40	0.28
glioblastoma cell line:T98G	10485-107A8	48.12	27.04	5.52	0.33
glioma cell line:GI-1	10413-106B8	53.89	30.75	6.44	0.59
globus pallidus - adult, donor10196	10175-103C4	7.29	25.51	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	8.54	24.17	0.49	0.49
globus pallidus, adult, donor10258	10367-105F7	1.37	15.06	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	11.72	28.78	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	117.46	53.84	19.58	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	131.14	32.79	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	78.40	26.13	26.13	0.00
granulosa cell tumor cell line:KGN	10624-108H3	40.00	18.24	2.24	0.32
hIPS +CCl2, biol_rep1	14383-156B9	47.29	18.82	5.97	0.92
hIPS +CCl2, biol_rep2	14384-156C1	40.70	23.78	7.32	0.46
hIPS +CCl2, biol_rep3	14385-156C2	58.61	33.49	7.73	0.00
hIPS, biol_rep1	14380-156B6	28.75	25.87	8.62	1.44
hIPS, biol_rep2	14381-156B7	56.93	19.89	9.60	0.69
hIPS, biol_rep3	14382-156B8	18.76	23.17	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	25.29	20.69	1.44	0.57
heart - mitral valve, adult	10205-103F7	14.05	24.52	1.20	0.30
heart - pulmonic valve, adult	10206-103F8	6.01	11.50	1.05	0.26
heart - tricuspid valve, adult	10207-103F9	11.66	14.99	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	19.79	32.24	1.43	0.00
heart, adult, diseased, donor1	10051-101G6	7.24	31.51	0.85	0.00
heart, adult, pool1	10016-101C7	11.27	25.30	0.23	0.00
heart, fetal, pool1	10046-101G1	9.04	13.96	0.62	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	90.71	41.65	10.49	2.16
hepatoblastoma cell line:HuH-6	10633-108I3	21.41	11.89	7.14	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	47.51	13.92	16.13	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	45.52	13.23	15.54	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	46.48	12.03	17.18	1.11
hepatoma cell line:Li-7	10484-107A7	12.79	9.68	2.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	30.15	12.86	6.03	0.40
hippocampus - adult, donor10196	10169-103B7	14.19	23.66	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	8.57	18.16	0.82	0.00
hippocampus, adult, donor10258	10374-105G5	5.98	23.40	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	13.39	26.44	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	56.15	28.69	7.93	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	42.02	23.76	8.44	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	46.72	24.12	6.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	28.19	19.17	4.51	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	23.24	19.88	6.97	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	39.10	15.94	6.83	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	29.49	21.02	5.26	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	27.57	25.21	6.25	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	35.45	23.77	6.67	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	42.62	28.18	9.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	35.20	23.95	6.11	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	34.34	35.69	9.43	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.50	17.21	7.20	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	38.32	24.56	9.33	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	34.04	18.33	7.85	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	32.26	19.47	5.35	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	20.93	22.68	9.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	30.49	18.99	10.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	27.88	24.30	4.71	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	31.83	27.28	9.55	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	25.69	26.63	7.83	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	35.27	32.01	4.90	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	32.22	29.61	9.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	40.06	27.20	5.98	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	36.03	22.17	8.31	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	40.23	23.68	9.13	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	50.22	22.46	11.84	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	27.11	21.48	6.34	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	31.36	30.41	8.87	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	35.41	20.58	6.05	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	33.10	37.75	10.34	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	25.24	35.86	6.64	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	35.66	31.30	9.24	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	44.99	34.00	10.48	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	46.95	39.38	6.06	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	52.42	36.97	12.77	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	41.06	23.43	7.49	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	47.69	23.62	8.47	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	36.59	18.54	5.85	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	22.62	25.06	7.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	6.51	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	27.80	16.55	3.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	20.80	30.10	8.76	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	27.87	28.23	6.51	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	23.13	30.96	7.47	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	27.45	33.41	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	27.22	24.38	7.18	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	27.48	20.20	3.77	0.54
immature langerhans cells, donor1	11904-125F5	5.81	9.69	0.73	0.00
immature langerhans cells, donor2	11905-125F6	10.30	15.84	0.00	0.00
insula, adult, pool1	10039-101F3	9.46	24.51	0.95	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	37.07	26.99	12.36	0.98
kidney, adult, pool1	10017-101C8	17.02	26.83	2.80	0.10
kidney, fetal, pool1	10045-101F9	16.34	25.96	3.25	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	25.85	19.46	1.99	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	88.20	44.93	16.73	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	31.56	16.15	4.59	0.18
left atrium, adult, donor1	10079-102A7	13.08	30.51	1.63	0.54
left ventricle, adult, donor1	10078-102A6	6.57	18.20	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	35.84	28.73	3.56	0.27
leiomyoma cell line:10964C	10569-108B2	121.07	85.50	11.14	2.51
leiomyoma cell line:15242A	10570-108B3	116.85	59.24	11.41	1.09
leiomyoma cell line:15425	10571-108B4	61.19	42.74	5.34	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	107.94	19.05	6.35	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	8.36	11.50	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	92.91	20.66	17.12	0.94
liposarcoma cell line:KMLS-1	10782-110G8	130.75	54.83	10.15	0.94
liposarcoma cell line:SW 872	10726-110A6	41.43	29.24	10.84	0.24
liver, adult, pool1	10018-101C9	5.67	8.59	0.49	0.00
liver, fetal, pool1	10086-102B5	19.75	20.70	2.82	0.00
locus coeruleus - adult, donor10196	10182-103D2	13.85	16.62	1.46	0.00
locus coeruleus, adult, donor10252	10165-103B3	11.81	25.65	1.66	0.37
locus coeruleus, adult, donor10258	10375-105G6	14.11	26.24	3.10	0.56
locus coeruleus, newborn, donor10223	10362-105F2	6.31	15.98	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	63.25	36.12	9.96	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	27.58	33.78	6.20	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	55.76	25.97	8.30	0.79
lung, adult, pool1	10019-101D1	12.88	17.48	1.77	0.12
lung, fetal, donor1	10068-101I5	18.84	22.55	1.43	0.00
lung, right lower lobe, adult, donor1	10075-102A3	12.37	23.83	1.83	0.46
lymph node, adult, donor1	10077-102A5	20.83	17.04	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	112.00	32.44	12.05	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	51.77	22.19	11.17	1.36
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	53.52	28.88	5.10	0.85
mature adipocyte, donor1	12231-129F8	0.89	2.66	0.44	0.00
mature adipocyte, donor2	12232-129F9	0.21	2.49	0.00	0.00
mature adipocyte, donor3	12233-129G1	1.42	3.32	0.00	0.00
mature adipocyte, donor4	12234-129G2	1.05	3.95	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	45.03	32.16	4.29	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	18.05	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	5.52	18.21	0.92	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	8.90	19.70	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	6.40	11.94	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	8.61	17.72	1.35	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	6.79	20.80	0.64	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	30.82	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	15.43	29.07	1.79	0.00
medulla oblongata - adult, donor10196	10174-103C3	21.42	13.63	2.60	0.00
medulla oblongata, adult, donor10252	10155-103A2	10.99	19.51	1.24	0.31
medulla oblongata, adult, pool1	10038-101F2	11.51	22.69	1.31	0.33
medulla oblongata, newborn, donor10223	10361-105F1	13.89	32.98	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	38.53	11.96	3.76	0.00
medulloblastoma cell line:ONS-76	10759-110E3	34.85	15.41	4.65	0.49
melanoma cell line:COLO 679	10514-107E1	40.11	39.67	5.89	0.86
melanoma cell line:G-361	10465-106H6	71.12	39.63	5.97	1.36
meningioma cell line:HKBMM	10691-109F7	37.45	17.73	4.34	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.91	9.69	13.22	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	47.44	19.18	5.44	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	105.87	44.80	11.81	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	59.44	34.72	4.91	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	60.87	55.49	12.84	2.07
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	68.69	30.20	6.18	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	78.95	49.88	10.59	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	158.25	79.82	13.88	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	95.26	44.97	8.58	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	63.95	34.16	6.90	1.38
mesenchymal precursor cell - cardiac, donor3	11754-123G8	86.61	28.12	5.84	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	78.86	31.73	8.64	2.03
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	75.54	26.89	5.69	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	48.42	31.62	5.93	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	101.43	37.91	7.47	1.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	97.74	42.59	4.19	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	123.93	46.55	10.41	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	74.41	32.35	10.06	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	105.73	51.93	6.93	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	81.39	39.67	4.79	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	63.35	23.50	5.87	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	78.16	32.28	7.92	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	74.05	26.00	5.08	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	107.87	56.70	5.89	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	84.70	39.20	6.87	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	36.63	32.00	2.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	83.57	49.32	7.31	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	69.32	34.28	5.37	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	80.36	41.62	7.85	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	86.88	32.35	5.55	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	70.61	38.83	8.71	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	78.86	46.37	7.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	79.77	39.69	5.89	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	80.17	39.39	3.71	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	241.52	144.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	89.41	45.86	6.92	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	78.98	35.25	5.80	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	83.64	44.22	9.37	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	60.13	30.80	5.87	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	66.80	39.61	10.07	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	80.24	44.21	5.73	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	86.77	42.53	6.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	147.66	82.03	8.20	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	139.45	41.32	20.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	101.33	58.46	9.74	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	116.40	64.02	14.55	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	167.92	85.29	9.06	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	107.95	68.69	8.18	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	111.17	67.64	8.16	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	117.53	69.26	18.89	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	120.21	72.52	9.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	147.78	47.67	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	100.80	49.81	7.71	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	129.16	51.18	8.53	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	81.16	54.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	107.68	68.41	10.13	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	110.02	81.74	8.97	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	133.25	77.37	6.45	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	119.75	43.91	19.96	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	99.87	89.54	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	103.50	68.05	6.93	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	109.63	81.83	8.74	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	76.05	68.39	5.90	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	77.30	61.72	5.30	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	100.25	58.81	6.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	43.76	34.30	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	56.50	33.38	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	37.86	48.19	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	25.73	34.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	23.55	40.37	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	34.98	34.35	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	30.63	44.33	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	34.89	50.15	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	32.94	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.81	30.34	1.82	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	36.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	26.36	37.89	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	57.94	51.39	3.37	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	40.56	41.54	1.95	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	38.71	52.97	2.04	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	53.39	21.66	7.74	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	85.76	54.34	3.31	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	24.33	15.75	3.01	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	17.09	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	39.56	25.48	1.13	0.10
mesothelioma cell line:Mero-25	10850-111F4	30.41	11.80	4.31	0.23
mesothelioma cell line:Mero-41	10851-111F5	34.23	37.89	2.93	0.49
mesothelioma cell line:Mero-48a	10852-111F6	46.72	19.04	3.99	0.22
mesothelioma cell line:Mero-82	10853-111F7	17.08	18.13	2.37	0.00
mesothelioma cell line:Mero-83	10854-111F8	63.83	29.96	3.06	0.34
mesothelioma cell line:Mero-84	10855-111F9	70.78	42.97	2.27	0.00
mesothelioma cell line:Mero-95	10856-111G1	52.80	26.29	6.83	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	36.94	15.24	1.82	0.50
mesothelioma cell line:NCI-H226	10846-111E9	45.79	14.30	3.08	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	35.19	30.58	1.37	0.17
mesothelioma cell line:NCI-H28	10845-111E8	28.75	36.39	1.53	0.25
mesothelioma cell line:No36	10857-111G2	103.73	44.04	5.22	0.00
mesothelioma cell line:ONE58	10858-111G3	101.61	36.31	6.23	0.81
migratory langerhans cells, donor1	11901-125F2	4.99	7.29	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	6.47	14.78	0.24	0.12
migratory langerhans cells, donor3	11903-125F4	16.15	23.69	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	42.12	35.59	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	108.09	41.33	7.84	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	30.18	22.58	3.23	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.07	16.37	2.85	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	73.36	43.98	9.98	1.85
myeloma cell line:PCM6	10474-106I6	110.89	101.21	6.52	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	37.54	26.38	6.09	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	58.25	39.82	6.86	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	35.32	44.35	3.01	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	32.28	42.51	1.47	0.29
nasal epithelial cells, donor2	12227-129F4	34.78	36.43	2.76	0.00
neuroblastoma cell line:CHP-134	10508-107D4	56.83	28.99	21.17	0.46
neuroblastoma cell line:NB-1	10539-107G8	46.21	20.21	3.93	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	30.58	22.35	4.01	0.63
neuroblastoma cell line:NH-12	10555-107I6	31.12	28.33	10.99	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.01	26.09	2.37	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	23.44	52.27	2.69	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	41.26	31.60	1.81	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	11.44	18.44	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	50.84	21.56	6.92	1.86
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	15.56	4.74	6.26	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	71.25	59.24	15.21	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	120.87	55.14	19.88	2.56
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	59.65	30.48	5.52	0.26
nucleus accumbens, adult, pool1	10037-101F1	8.81	19.69	1.03	0.19
occipital cortex - adult, donor10196	10172-103C1	12.36	28.85	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	6.71	17.18	1.61	0.00
occipital cortex, newborn, donor10223	10355-105E4	26.57	32.03	2.91	0.00
occipital lobe, adult, donor1	10076-102A4	11.28	23.88	1.57	0.52
occipital lobe, fetal, donor1	10073-102A1	18.45	40.76	2.57	0.00
occipital pole, adult, pool1	10036-101E9	11.43	21.13	1.02	0.32
olfactory region, adult	10195-103E6	8.98	22.16	0.96	0.00
optic nerve, donor1	10277-104E7	8.00	32.02	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	64.36	20.50	12.76	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	61.82	47.54	6.32	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.84	16.09	2.20	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	24.95	13.63	4.27	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	38.51	26.46	4.41	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	45.78	25.23	5.61	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	73.80	29.69	12.72	1.70
ovary, adult, pool1	10020-101D2	8.47	16.16	1.22	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	72.23	21.27	6.78	1.10
pancreas, adult, donor1	10049-101G4	147.68	90.30	20.69	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	39.97	27.95	4.75	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	36.46	13.97	7.67	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	40.90	20.04	4.47	0.50
paracentral gyrus, adult, pool1	10035-101E8	10.07	17.21	0.73	0.00
parietal cortex, adult, donor10258	10373-105G4	5.87	17.62	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	4.70	17.87	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	3.99	20.81	2.00	0.29
parietal lobe, adult, pool1	10034-101E7	9.16	19.47	1.15	0.35
parietal lobe, fetal, donor1	10072-101I9	18.43	32.97	3.88	0.00
parietal lobe, newborn, donor10223	10356-105E5	18.69	26.17	2.62	0.00
parotid gland, adult	10199-103F1	623.45	92.50	97.43	9.25
penis, adult	10200-103F2	8.06	20.41	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	38.67	58.94	0.56	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	54.93	26.66	11.07	0.44
pineal gland - adult, donor10196	10179-103C8	54.18	37.41	6.45	0.65
pineal gland, adult, donor10252	10160-103A7	25.47	33.16	2.96	0.00
pineal gland, adult, donor10258	10377-105G8	26.96	35.74	5.02	0.00
pituitary gland - adult, donor10196	10180-103C9	88.03	41.48	16.19	1.01
pituitary gland, adult, donor10252	10162-103A9	66.19	50.03	7.30	1.04
pituitary gland, adult, donor10258	10378-105G9	68.10	41.71	10.21	0.85
placenta, adult, pool1	10021-101D3	49.34	39.78	4.52	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	33.77	15.49	5.16	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	27.55	23.81	2.65	0.78
pons, adult, pool1	10033-101E6	16.44	19.11	1.38	0.26
postcentral gyrus, adult, pool1	10032-101E5	11.59	21.97	0.96	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	100.39	37.65	12.55	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	132.19	60.59	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	70.41	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	36.27	19.81	3.64	0.29
prostate cancer cell line:PC-3	10439-106E7	60.44	26.14	5.08	0.73
prostate, adult, pool1	10022-101D4	14.78	30.47	2.45	0.27
putamen, adult, donor10196	10176-103C5	4.49	24.79	0.24	0.00
putamen, adult, donor10252	10152-102I8	5.88	31.37	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	22.95	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	4.59	14.50	0.72	0.24
putamen, newborn, donor10223	10365-105F5	3.75	14.99	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	32.29	24.73	5.24	0.29
rectum, fetal, donor1	10067-101I4	26.43	37.56	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	97.52	43.46	9.33	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	97.34	46.81	2.49	0.83
retina, adult, pool1	10030-101E3	14.71	20.97	1.69	0.10
retinoblastoma cell line:Y79	10475-106I7	34.81	8.83	10.65	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	31.47	27.05	1.48	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	19.97	17.43	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	41.68	28.80	3.03	0.00
salivary acinar cells, donor1	11771-123I7	27.19	29.30	2.91	0.00
salivary acinar cells, donor2	11772-123I8	17.76	38.69	2.48	0.14
salivary acinar cells, donor3	11773-123I9	15.23	24.50	0.66	0.00
salivary gland, adult, pool1	10093-102C3	730.38	138.41	89.80	11.44
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	19.56	25.80	1.01	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	19.40	23.39	1.76	0.12
seminal vesicle, adult	10201-103F3	79.36	58.73	13.76	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.65	13.60	2.92	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.85	23.65	2.26	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	20.07	17.06	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	50.77	19.75	7.92	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	38.02	17.35	11.16	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	37.42	26.32	5.29	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	0.00	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	2.52	4.80	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	21.11	24.12	0.00	1.01
skin, adult, donor1	10074-102A2	33.93	61.07	13.57	0.00
skin, fetal, donor1	10065-101I2	36.61	45.45	5.68	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	37.35	12.67	15.01	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	34.99	23.64	5.67	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	36.62	83.65	2.51	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	44.34	25.71	7.91	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	116.94	15.92	22.68	2.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	25.93	17.87	6.54	0.22
small intestine, adult, pool1	10024-101D6	9.79	18.27	1.43	0.12
small intestine, fetal, donor1	10064-101I1	18.92	25.80	2.95	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	154.90	109.76	26.16	0.51
smooth muscle, adult, pool1	10048-101G3	6.20	19.38	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	71.83	38.33	12.60	0.80
spinal cord - adult, donor10196	10181-103D1	8.03	19.96	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	5.13	22.47	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	4.15	24.21	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	20.12	32.93	3.66	1.22
spinal cord, newborn, donor10223	10359-105E8	9.18	18.37	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	52.87	20.31	4.63	0.75
spleen, adult, pool1	10025-101D7	19.93	15.09	2.09	0.44
spleen, fetal, pool1	10044-101F8	13.98	17.48	0.95	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	20.81	16.15	2.07	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	22.97	14.24	3.04	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.45	35.29	2.45	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	53.17	18.76	11.34	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	28.59	12.27	12.04	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	31.35	24.15	8.05	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	22.85	18.62	2.96	0.00
stomach, fetal, donor1	10062-101H8	36.31	36.31	5.34	1.07
submaxillary gland, adult	10202-103F4	442.64	83.74	70.64	4.56
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	5.61	23.26	0.62	0.00
substantia nigra, adult, donor10258	10371-105G2	12.93	21.21	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	15.54	30.38	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	49.75	32.78	5.50	0.46
temporal lobe, adult, pool1	10031-101E4	10.60	25.26	1.27	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	20.66	30.63	2.14	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	18.46	36.92	1.32	0.00
tenocyte, donor1	11763-123H8	96.00	53.76	7.68	1.40
tenocyte, donor2	11765-123I1	41.97	53.03	3.82	0.76
tenocyte, donor3	11768-123I4	89.70	75.25	7.78	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	43.51	20.57	5.44	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	22.51	11.41	1.54	0.31
teratocarcinoma cell line:PA-1	10807-111A6	19.84	14.41	2.63	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.71	17.39	3.30	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	13.24	17.40	1.51	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	26.72	15.60	2.84	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	19.22	22.80	2.61	0.00
testis, adult, pool1	10026-101D8	22.55	37.69	2.90	0.32
testis, adult, pool2	10096-102C6	26.16	65.86	3.16	0.00
thalamus - adult, donor10196	10168-103B6	6.62	26.50	0.00	0.00
thalamus, adult, donor10252	10154-103A1	4.69	17.66	0.78	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	47.73	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.05	18.77	1.98	0.16
thalamus, newborn, donor10223	10366-105F6	17.26	17.83	0.58	0.00
throat, adult	10209-103G2	50.18	33.21	5.49	0.25
throat, fetal, donor1	10061-101H7	27.42	37.17	4.57	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	30.80	24.25	7.75	0.40
thymus, adult, pool1	10027-101D9	13.62	14.02	3.48	0.10
thymus, fetal, pool1	10043-101F7	15.59	17.56	2.29	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	30.32	16.49	6.65	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	47.22	36.18	3.21	0.00
thyroid, adult, pool1	10028-101E1	24.63	55.15	1.96	0.19
thyroid, fetal, donor1	10060-101H6	34.54	69.87	4.75	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	36.96	15.40	0.00
tongue, adult	10203-103F5	44.42	27.21	5.12	0.23
tongue, fetal, donor1	10059-101H5	45.32	23.65	6.31	0.39
tonsil, adult, pool1	10047-101G2	67.92	44.08	7.01	0.30
trachea, adult, pool1	10029-101E2	68.38	39.26	8.59	0.82
trachea, fetal, donor1	10058-101H4	95.40	41.55	24.24	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	72.27	31.18	8.50	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	27.25	13.68	5.67	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	18.49	12.53	0.63	0.00
tridermal teratoma cell line:HGRT	10694-109G1	39.95	19.03	7.61	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	30.73	23.28	5.25	0.08
umbilical cord, fetal, donor1	10057-101H3	35.47	37.56	8.35	0.00
uterus, adult, pool1	10100-102D1	15.19	35.15	2.05	0.00
uterus, fetal, donor1	10055-101H1	33.28	30.20	7.68	2.56
vagina, adult	10204-103F6	14.22	14.86	0.65	0.00
vein, adult	10191-103E2	10.96	14.69	1.75	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	34.71	20.03	2.14	0.00